Hims & Hers grants David B. Wells 1,051 stock units

Available on EDGAR 11/13/2026 - 04:18 PM EST Accepted by SEC EDGAR 11/13/2026 - 04:17 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Hims & Hers Health, Inc. director David B. Wells received 1,051 restricted stock units on November 11, 2026, representing a direct award tied to Class A common stock. The units each represent a contingent right to receive one share. They were granted in lieu of $30,000 in third-quarter 2026 director retainer fees, using a grant price of $28.53, and are scheduled to vest in full on the company's next quarterly vesting date.

Insider Trade Summary

Grant/Award: 1,051 shares

Grant/Award 1 txn

Insider WELLS DAVID B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit F1	1,051	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 1,051 units (Direct)

Holdings Before and After: Restricted Stock Unit, 0 to 1,051 units (Direct)

Footnotes (1)

1. F1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the third quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $30,000 by the grant price of $28.53. The RSUs will vest in full on the Company's next quarterly vesting date.

Key Figures

Restricted stock units granted: 1,051 RSUs Foregone director retainer fees: $30,000 Grant price: $28.53 +1 more

4 metrics

Restricted stock units granted 1,051 RSUs Direct award to David B. Wells on November 11, 2026

Foregone director retainer fees $30,000 Third-quarter 2026 fees replaced by the RSU award

Grant price $28.53 Used to calculate the number of RSUs granted

Direct RSU position after award 1,051 RSUs David B. Wells' reported position following the transaction

Key Terms

Restricted Stock Units, contingent right, Director Compensation Policy

3 terms

Restricted Stock Units financial

"granted Restricted Stock Units ("RSUs")"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"represent a contingent right to receive one share"

Director Compensation Policy financial

"pursuant to the Issuer's Director Compensation Policy"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HIMS RSUs did director David B. Wells receive?

David B. Wells received 1,051 restricted stock units on November 11, 2026. Each unit represents a contingent right to receive one share of Class A common stock.

Why did HIMS grant David B. Wells RSUs, and when do they vest?

The RSUs were granted in lieu of $30,000 in third-quarter 2026 director retainer fees and are scheduled to vest in full on the company's next quarterly vesting date. The grant price used to calculate the award was $28.53.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WELLS DAVID B

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CALIFORNIA 94123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	11/11/2026		A		1,051		(1)	(1)	Class A Common Stock	1,051	$0	1,051	D

Explanation of Responses:

1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the third quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $30,000 by the grant price of $28.53. The RSUs will vest in full on the Company's next quarterly vesting date.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for David B Wells	11/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)